The anti-fibrotic effect of green tea with a high catechin content in the galactosamine-injured rat liver

Biomedical Research

Volumn 28, Issue 1, 2007, Pages 43-48

  Abe, Kouichi ^a,b   Suzuki, Takuji ^a   Ijiri, Mitsuhiro ^a   Koyama, Yu ^c   Isemura, Mamoru ^a   Kinae, Naohide ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b KUMIAI CHEMICAL INDUSTRY CO LTD   (Japan)

^c HAMAMATSU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; CATECHIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1 CHAIN; GALACTOSAMINE; MESSENGER RNA; RNA; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA;

ANIMALS; CATECHIN; FIBROSIS; GALACTOSAMINE; HEPATITIS, TOXIC; LIVER; RATS; TEA;

RATTUS;

EID: 33947649126     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.28.43     Document Type: Article

References (22)

1. Abe K, Ijiri M, Suzuki T, Taguchi K, Koyama Y and Isemura M (2005) Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed Res 26, 187-192.
2. Castilla A, Prieto J and Fausto N (1991) Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324, 933-940.
3. Czaja MJ, Flanders KC, Biempica L, Klein C, Zern MA and Weiner FR (1989) Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury. Growth Factors 1, 219-226.
4. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L and Zern MA (1989) In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol 108, 2477-2482.
5. Date M, Matsuzaki K, Matsushita M, Tahashi Y, Furukawa F and Inoue K (2000) Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut 46, 719-724.
6. Friedman SL (1993) Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328, 1828-1835.
7. Gressner AM, Weiskirchen R, Breitkopf K and Dooley S (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7, d793-807.
8. Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, Kobayashi N and Nakamuta M (2005) Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J Lab Clin Med 145, 316-322.
9. Ikeda K, Saitoh S, Suzuki Y, Kobayashi M, Tsubota A, Koida I, Arase Y, Fukuda M, Chayama K, Murashima N and Kumada H (1998) Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 28, 930-938.
10. Ishak KG, Zimmerman HJ and Ray MB (1991) Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15, 45-66.
11. Jonker AM, Dijkhuis FW, Boes A, Hardonk MJ and Grond J (1992) Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology 15, 423-431.
12. Jonker AM, Dijkhuis FW, Hardonk MJ, Moerkerk P, Ten Kate J and Grond J (1994) Immunohistochemical study of hepatic fibrosis induced in rats by multiple galactosamine injections. Hepatology 19, 775-781.
13. Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP and Lohse AW (2001) Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat 8, 430-437.
14. Keppler D, Lesch R, Reutter W and Decker K (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9, 279-290.
15. Kim KH, Kim HC, Hwang MY, Oh HK, Lee TS, Chang YC, Song HJ, Won NH and Park KK (2006) The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun 343, 1072-1078.
16. Li YM, Zhang XG, Zhou HL, Chen SH, Zhang Y and Yu CH (2004) Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease. Hepatobiliary Pancreat Dis Int 3, 577-579.
17. Nakamuta M, Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Kobayashi N and Enjoji M (2005) Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int J Mol Med 16, 677-681.
18. Stachlewitz RF, Seabra V, Bradford B, Bradham CA, Rusyn I, Germolec D and Thurman RG (1999) Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells. Hepatology 29, 737-745.
19. Suzuki T, Tazoe H, Taguchi K, Koyama Y, Ichikawa H, Hayakawa S, Munakata H and Isemura M (2006) DNA microarray analysis of changes in gene expression induced by 1,25-dihydroxyvitamin D3 in human promyelocytic leukemia HL-60 cells. Biomed Res 27, 99-109.
20. Ujike K, Shinji T, Hirasaki S, Shiraha H, Nakamura M, Tsuji T and Koide N (2000) Kinetics of expression of connective tissue growth factor gene during liver regeneration after partial hepatectomy and D-galactosamine-induced liver injury in rats. Biochem Biophys Res Commun 277, 448-454.
21. Yumei F, Zhou Y, Zheng S and Chen A (2006) The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest 86, 697-709.
22. Zhong Z, Froh M, Lehnert M, Schoonhoven R, Yang L, Lind H, Lemasters JJ and Thurman RG (2003) Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats. Am J Physiol Gastrointest Liver Physiol 285, G1004-G1013.